Rising healthcare habits such as smoking, increasing disposable income, rise in awareness among public and increasing strategic initiatives such as product launch or collaboration are key factors contributing to high CAGR of complexion disorders market during the forecast period.
According to the current analysis of Reports and Data, the global Complexion Disorders Treatment Market valued at USD 5.35 billion in 2018 and is expected to reach USD 10.22 billion by the year 2026, at a CAGR of 8.4%. Complexion is the skin disorder formed because of the exceeding levels of melanin, a pigment made by melanocytes. The oxidation of tyrosine, which is an amino acid, results in the production of melanin. Keratinocytes carry melanin; although it is harmless, it creates a dullness in the skin. It mostly happens to the face and can also affect the other parts of the body. When melanocytes are affected, the melanin production of the body fluctuates. This defect either darkens or lightens the skin. Higher production of melanin results in the darkening of the skin, whereas less production of melanin makes the skin lighter. Hypercomplexion is mostly seen in the Caucasian population, and smoking has also contributed to the growth of the market, the market is even expected to grow even more in the coming years.
Topical therapy includes Hydroquinone as a first-line agent also with a retinoid for treatment melasma due to its highest rate in the white population, which comprises 55 to 60% of the world population. Hormonal changes, pregnancy, and birth control pills are responsible for the occurrence of melasma in 90% of women throughout the world. Treatments like laser therapy and skin grafting methods, physical therapy in the form of lesion removal, photo-therapy are the other treatments used in complexion disorders.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC])@ https://www.reportsanddata.com/sample-enquiry-form/2629
The report provides comprehensive assessment of the market covering key elements such as revenue estimations, cost analysis, import/export, production and consumption trends, CAGR, gross margin, and supply demand patterns. It also sheds light on recent technological developments, product advancements, and research and development activities in the region.
The report examines the key players operating in the market along with their market position, market share, revenue, gross margin, and business strategies. SWOT analysis and Porter’s Five Forces Analysis are used to examine and assess the market and its players. It also covers recent mergers and acquisitions, joint ventures, collaborations, agreements, partnerships, and product launches and brand promotions.
Key companies profiled in the report include:
Bayer AG (Germany), Pierre Fabre Pharmaceuticals (France), EpiPharm AG (Swizzerland), SkinCeuticals International(US), Galderma laboratories (US), VIVIERPHARMA(Canada), Obagi Cosmeceuticals LLC (US)., La Roche-Posay, ALLERGAN (Dublin Ireland)
Market Segmentation by Types:
Treatment Outlook (Revenue in Million USD; 2017–2024)
- Chemical Peels
- Microdermabrasion
- Topical Drugs
- Phototherapy
- Laser Therapy
- Skin Grafting
- Drugs
- Others
Disease Condition Outlook (Revenue in Million USD; 2017–2024)
- Acne Vulgaris
- Vitiligo
- Melasma
- Albinism
- Solar Lentigines
- Post-Inflammatory Hypercomplexion
End Use Outlook (Revenue in Million USD; 2017–2024)
- Dermatology Centers
- Hospitals
- Aesthetic Clinics
Order this Report @ https://www.reportsanddata.com/report-pricing/2629
Regional analysis covers in-depth analysis of analysis of the revenue, market share, and growth rate of the global Complexion Disorders market in each region for the forecast period of 2021-2028. The report covers production and consumption rate, current and emerging trends, import/export, supply and demand, and presence of key players in each region.
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- U.K.
- Italy
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Rest of MEA
Further key findings from the report suggest
- Various clinical studies are being carried out for example, in the year 2019 nationwide phase II clinical trial was coordinated by Tufts Medical Center in Boston, for a topical cream ruxolitinib which was found extremely effective in reversing the effects of vitiligo, and also had decreased the skin complexion for nearly half of the clinical trial participants
- Growing awareness regarding cosmeceutical and cosmetics products, such as in anti-aging, sun care, and hair care and beauty, is expected to boost up the growth potential in the coming future. Introducing natural and plant-based ingredients have played a crucial role in exceeding the demand for cosmeceutical products across the world, especially in the Asia-Pacific region.
- Microdermabrasion devises market is emerging due to its advances and also due to the effects obtained, factors such as financial stability, technological advancements, and are anticipated to stimulate the market in the forecast period.
- Microdermabrasion had resulted in wound healing and skin remodeling. As per the technique of coarse-grit hand piece that includes cytokeratin 16, gives optimal responses to injuries in the outer layer of the skin, it also contains antimicrobial peptides that fights infection; matrix metalloproteinase breaks down skin's structural proteins and allows rebuilding for both collagen precursors and other substances that form the pathway to its production. This kind of treatment is generally beneficial for aging skin. These molecular changes were not seen in individuals who received microdermabrasion with the medium-grit hand piece
- On the basis of treatment type chemical peels used for complexion disorders is expected to reach 3.77 billion by 2026 and held largest share in the year 2018
- Acne vulgaris is expected to grow at a highest CAGR 8.9% in forecasted year. Rising smoking habits, sedentary lifestyle and worldwide rising popularity of fast food are expected to drive the market growth
- Melasma has been on the rise, especially in women due to contraceptives, pregnancy, UV rays, and treatment includes photo protective agents, skin lighters, antioxidants, exfoliates, and resurfacing procedures. First-line therapy includes photo protection and topical agents. Laser treatment is included in the second-line treatment.
Request a customization of the report @ https://www.reportsanddata.com/request-customization-form/2629
Thank you for reading our report. For further inquiry, please connect with us and our team will make sure the report is customized according to your requirements.
Explore More Industry Research by Reports and Data:
Anatomical Models Market @ https://www.biospace.com/article/anatomical-models-market-expected-to-reach-usd-57-03-billion-by-2028-/
Sacral Neuromodulation Market @ https://www.biospace.com/article/sacral-neuromodulation-market-expected-to-reach-usd-3-498-2-million-by-2028-/
Pruritus Therapeutics Market @ https://www.biospace.com/article/pruritus-therapeutics-market-size-worth-usd-19-98-billion-by-2028-/
Hyperbaric Oxygen Therapy (HBOT) Devices/Equipment Market @ https://www.biospace.com/article/hyperbaric-oxygen-therapy-hbot-devices-equipment-market-expected-to-reach-usd-4-65-billion-in-2028-/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Contact Us:
John W
Head of Business Development
Reports and Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
